Watanabe, S., Hayashi, H., & Nakagawa, K. (2016). Is afatinib a treatment option for brain metastases in patients with EGFR mutation-positive non-small cell lung cancer? Ann Transl Med.
Citação norma ChicagoWatanabe, Satomi, Hidetoshi Hayashi, and Kazuhiko Nakagawa. "Is Afatinib a Treatment Option for Brain Metastases in Patients With EGFR Mutation-positive Non-small Cell Lung Cancer?" Ann Transl Med 2016.
MLA citiranjeWatanabe, Satomi, Hidetoshi Hayashi, and Kazuhiko Nakagawa. "Is Afatinib a Treatment Option for Brain Metastases in Patients With EGFR Mutation-positive Non-small Cell Lung Cancer?" Ann Transl Med 2016.
Opozorilo: Ti citati niso vedno 100% točni.